High Telehealth Use Tied to Increased Health Care Utilization, Cost
By Lori Solomon HealthDay Reporter
TUESDAY, May 14, 2024 -- Higher telehealth use in a hospital service area is tied to increased health care utilization and cost, according to a study published online May 13 in JAMA Network Open.
Morteza Saharkhiz, Ph.D., from Meta Platforms Inc. in Menlo Park, California, and colleagues evaluated the association between telehealth use and outcomes for all Medicare fee-for-service beneficiaries. The analysis included 3,436 hospital service areas for approximately 30 million Medicare beneficiaries.
The researchers found that compared with areas with low telehealth use, those living in high-use areas had more ambulatory care-sensitive hospitalizations (1.63 additional hospitalizations per 1,000 beneficiaries), more clinician encounters (0.30 additional encounters per beneficiary per semester), and higher total cost of care ($164.99 higher cost per beneficiary per semester). The groups did not significantly differ for ambulatory care-sensitive emergency department visits.
“Data from the COVID-19 pandemic suggest that higher levels of telehealth use may be associated with increased access to care and potentially lower quality of care (evidenced by increases in ambulatory care–sensitive hospitalizations)," the authors write. "Replication of this analysis with post–COVID-19 data is needed to fully understand the impacts of the telehealth expansion."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.